worldwide@absin.cn
  • Sign in or Register
    My account Recent orders Wish list Address management

    Sign out

  • Cart 0
    The latest additions

      0 items in total

      Subtotal $0.00

      Go to cart
    • English
      Chinese
    爱必信(absin)官网
    爱必信(absin)官网

    000000 Citations

    Home
    Products
    Promotions
    Resources
    Product ApplicationFAQsNewsCitationsElectronic DocumentsCalculation Tools
    About us
    Contact us
    worldwide@absin.cn
    • Sign in or Register
      My account Recent orders Wish list Address management

      Sign out

    • Cart 0
      The latest additions

        0 items in total

        Subtotal $0.00

        Go to cart
      • English
        Chinese
      爱必信(absin)官网
      爱必信(absin)官网

      000000 Citations

      Home
      Products
      Promotions
      Resources
      Product ApplicationFAQsNewsCitationsElectronic DocumentsCalculation Tools
      About us
      Contact us
      HomeProduct ApplicationWhich Experiments Suit Exosome-Depleted Fetal Bovine Serum? A Practical Guide to Cell Culture and Supernatant Collection
      Search

      Which Experiments Suit Exosome-Depleted Fetal Bovine Serum? A Practical Guide to Cell Culture and Supernatant Collection

      November 04, 2026

      Clicks:61

      Share:
      Share This on facebook
      Share This on twitter
      Share This on pinterest
      Share This on linkedin
      Share This on skype
      Share This on telegram
      Share This on whatsapp
      Share This on wechat

      Which Experiments Suit Exosome-Depleted Fetal Bovine Serum? A Practical Guide to Cell Culture and Supernatant Collection

      1. Four Experimental Scenarios That Strongly Justify Switching to Exosome-Depleted FBS

      1.1 Exosome isolation and characterisation

      This covers the extraction of extracellular vesicles by differential ultracentrifugation, density gradient centrifugation or PEG precipitation, followed by NTA particle size and concentration quantification, transmission electron microscopy (TEM) morphology observation, and western blot validation of the markers CD9, CD63, CD81, TSG101 and Alix. This is the most basic application scenario for exosome-depleted serum.

      1.2 Exosome functional and mechanistic studies

      Examples include invasion and migration assays mediated by tumour-derived exosomes, paracrine regulation by stem cell exosomes, inflammatory modulation by immune cell vesicles, and gain- or loss-of-function experiments on the effects of exosomes on target cell proliferation, apoptosis and differentiation. Eliminating the background activity of serum vesicles is essential to confirm that the observed phenotype is genuinely mediated by cell-secreted exosomes.

      1.3 Exosome omics and sequencing

      High-throughput omics including label-free and TMT proteomics, transcriptomics (miRNA-seq, mRNA-seq, circRNA-seq) and metabolomics place strict demands on sample purity. Bovine contaminants lead to confusing mass-spectrometric peaks and ambiguous read alignment, which markedly reduces data quality. Reviewers at high-impact journals now commonly require authors to state whether the culture medium used exosome-depleted serum.

      1.4 Disease microenvironment models and drug delivery development

      In vitro tumour microenvironment modelling, engineering of exosomes as drug carriers, and liquid biopsy biomarker discovery all require precisely quantifiable and reproducible exosome preparations, for which exosome-depleted serum is the foundation of experimental reliability.

      2. Practical Guide to Exosome-Depleted FBS Culture and Supernatant Collection

      Choosing the right serum must be combined with a standardised workflow to minimise background interference. The following points are critical in exosome culture experiments.

      2.1 Medium exchange timing

      Standard fetal bovine serum may be used during routine cell expansion. Once cells reach 60-70% confluence, discard the old medium, gently rinse the cells 2-3 times with PBS, and replace it with complete medium containing exosome-depleted serum.

      2.2 Supernatant collection

      A window of 24-48 hours is recommended. Shorter collection yields insufficient secreted exosomes for detection, whereas longer periods increase cell apoptosis and necrosis, generating debris that raises non-vesicular particulate background. The optimal duration should be optimised for each cell line.

      2.3 Serum freeze-thaw handling

      Repeated freeze-thaw cycles may precipitate trace protein crystals in exosome-depleted serum. Before NTA analysis the serum can be clarified by low-speed centrifugation at 3000 x g for 5-10 minutes to remove precipitates, a step that does not affect cell culture performance. Aliquot into single-use volumes to avoid repeated freeze-thaw.

      2.4 Aseptic handling

      A full aseptic protocol must be maintained throughout. Qualified exosome-depleted FBS is supplied with 0.1 um sterile filtration and has been tested for mycoplasma and exogenous viruses, so it can be used directly without further filtration. Self-filtration may instead introduce particulate contamination.

      2.5 Cell type compatibility

      Exosome-depleted serum is compatible with the great majority of common cell lines, including tumour cells, mesenchymal stem cells (MSC), epithelial cells, endothelial cells and immune cells. For primary cells with exceptionally demanding nutritional requirements, small-scale pilot experiments to confirm proliferative performance are recommended.

      3. Selecting a Reliable Exosome-Depleted FBS: Quality-Control Indicators

      The market offers many exosome-depleted sera of variable quality. Selection should not be based on price alone but on the following quality-control indicators.

      3.1 Removal efficiency

      Prefer products with explicit quantitative metrics such as CD63 content or exosome removal rate. For instance, CD63 below 3.125 pg/mL or a removal rate of 95% or more is far more informative than vague descriptions such as "highly efficient removal".

      3.2 Cell culture performance

      Validation data such as population doubling time, colony formation efficiency and viability should be available, confirming that the vesicle-depletion process has not excessively damaged growth factors.

      3.3 Origin and safety

      The serum should originate from BSE-free regions, with a complete traceability system, endotoxin at 10 EU/mL or below, and documented mycoplasma and virus testing.

      3.4 Batch stability

      Exosome studies often run over long periods, so continued supply of the same batch is important. A supplier with stable supply and minimal inter-batch variation avoids data drift caused by switching serum mid-study.

      4. Quality-Control Metrics for a Reliable Exosome-Depleted Serum

      A reliable exosome-depleted serum should meet four conditions simultaneously: a defined and quantified removal rate, retained growth factor and nutrient content, cell-type-matched culture performance, and batch-to-batch consistency with documented mycoplasma and endotoxin testing. When these criteria are met, exosome isolation, functional studies and omics workflows become technically reproducible, and the resulting data can be attributed to the cellular source rather than to the serum background.


      Contact Absin

      Absin provides antibodies, proteins, ELISA kits, cell culture, detection kits, and other research reagents. If you have any product needs, please contact us.

      Absin Bioscience Inc.

      worldwide@absin.cn
      Follow us on Facebook: Absin Bio
       
       

      Ordering Details

      Email: worldwide@absin.cn

      Thanks for your interesting of our products, we will reply to you in 1-2 working days.

      • Products
      • Resources
      • Product Application
      • Calculation Tools
      • FAQs
      • Citations
      • Electronic Documents
      • About us
      • Company Profile
      • Ordering Tools
      • Customer Support
      • Contact us
      Email: worldwide@absin.cn
      picture invalid picture invalid
      ICP:16001690 Absin Bioscience Inc.All rights reserved.